Can the eye reveal how the body reacts to nerve stimulation?
NCT ID NCT07746167
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This observational study looks at how the pupil of the eye reacts to increasing levels of nerve stimulation in healthy adults. Researchers will use a device called AlgometRx to deliver mild electrical stimuli and measure pupil dilation, which may reflect the body's response to pain. The goal is to understand the relationship between stimulation intensity and pupil response, which could inform future pain assessment methods.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- This could help refine how pain is measured objectively, potentially leading to better ways to assess and manage pain without relying solely on self-report.
- What could go wrong
- This is an observational study in healthy volunteers, so results may not apply to people with pain conditions. The measurements may also vary between individuals, limiting generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study will enroll up to 60 healthy adult volunteers between the ages of 18 and 60
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-60 years. * In good general health (self-reported). * Able and willing to provide written informed consent. Exclusion Criteria: * Eye pathology that prevents accurate pupillometry. * Pregnancy (Self-Report) * Diagnosis of autoimmune disorders. * Diagnosis of any neuropathic disorder * Inability to complete questionnaires.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy participants are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Children's National Hospital
RECRUITINGWashington D.C., District of Columbia, 20010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body